Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2010-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff
NCT04346186
Community Acquired Pneumonia in Telemark and Ostfold
NCT00467701
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
NCT04706390
The Corona and COVID-19 Study in Telemark and Agder
NCT04514003
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
By using data extracted from the GP offices EPR databases and the microbiology laboratories we will investigate the study hypothesis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control area
In the control areas we will monitor the prevalence and treatment of communicable diseases without giving the participants online access to disease surveillance information
No interventions assigned to this group
Intervention area
In these areas we will give study participants online access to epidemiological data for communicable diseases
Online disease surveillance data access
In the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Online disease surveillance data access
In the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Tromso
OTHER
The Royal Norwegian Ministry of Health
OTHER
Norwegian Health Network (state owned enterprise)
UNKNOWN
University Hospital of North Norway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Gustav Bellika, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Tromsø, Department of Computer Science
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID 3746/ HST954-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.